SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,278,283 | -11.3% | 46,365 | -3.3% | 0.01% | -7.7% |
| Q2 2023 | $1,441,828 | -17.9% | 47,965 | -1.1% | 0.01% | -23.5% |
| Q1 2023 | $1,756,394 | +135424.2% | 48,479 | +33.4% | 0.02% | -15.0% |
| Q4 2022 | $1,296 | -99.9% | 36,343 | -5.5% | 0.02% | -4.8% |
| Q3 2022 | $1,302,000 | +16.7% | 38,476 | -0.3% | 0.02% | +16.7% |
| Q2 2022 | $1,116,000 | -8.4% | 38,606 | +2.4% | 0.02% | +5.9% |
| Q1 2022 | $1,219,000 | +9.0% | 37,703 | -1.7% | 0.02% | +21.4% |
| Q4 2021 | $1,118,000 | +6.6% | 38,341 | -2.5% | 0.01% | +7.7% |
| Q3 2021 | $1,049,000 | -13.8% | 39,314 | -0.5% | 0.01% | -7.1% |
| Q2 2021 | $1,217,000 | +17.6% | 39,511 | -0.1% | 0.01% | +7.7% |
| Q1 2021 | $1,035,000 | -2.7% | 39,538 | -6.5% | 0.01% | 0.0% |
| Q4 2020 | $1,064,000 | +3.8% | 42,303 | -14.0% | 0.01% | -7.1% |
| Q3 2020 | $1,025,000 | +4.0% | 49,195 | +18.5% | 0.01% | -12.5% |
| Q2 2020 | $986,000 | +22.8% | 41,510 | -6.9% | 0.02% | +6.7% |
| Q1 2020 | $803,000 | -5.6% | 44,610 | +24.3% | 0.02% | +15.4% |
| Q4 2019 | $851,000 | -13.3% | 35,885 | +0.5% | 0.01% | -18.8% |
| Q3 2019 | $981,000 | -16.6% | 35,699 | +0.4% | 0.02% | -11.1% |
| Q2 2019 | $1,176,000 | -5.5% | 35,552 | +0.1% | 0.02% | -10.0% |
| Q1 2019 | $1,245,000 | +9.6% | 35,524 | +3.9% | 0.02% | 0.0% |
| Q4 2018 | $1,136,000 | -31.3% | 34,196 | +4.1% | 0.02% | -13.0% |
| Q3 2018 | $1,654,000 | -17.3% | 32,853 | -1.7% | 0.02% | -14.8% |
| Q2 2018 | $2,001,000 | +28.0% | 33,430 | -2.0% | 0.03% | +28.6% |
| Q1 2018 | $1,563,000 | +13.2% | 34,118 | -1.5% | 0.02% | +23.5% |
| Q4 2017 | $1,381,000 | -6.8% | 34,651 | -6.4% | 0.02% | -10.5% |
| Q3 2017 | $1,481,000 | -6.4% | 37,013 | +0.8% | 0.02% | -9.5% |
| Q2 2017 | $1,582,000 | +39.3% | 36,711 | +1.2% | 0.02% | +40.0% |
| Q1 2017 | $1,136,000 | +24.6% | 36,288 | +0.5% | 0.02% | +25.0% |
| Q4 2016 | $912,000 | -2.3% | 36,110 | -4.3% | 0.01% | -7.7% |
| Q3 2016 | $933,000 | +73.1% | 37,715 | +42.6% | 0.01% | +85.7% |
| Q2 2016 | $539,000 | +28.9% | 26,452 | -3.4% | 0.01% | +40.0% |
| Q1 2016 | $418,000 | +9.7% | 27,393 | -3.3% | 0.01% | 0.0% |
| Q4 2015 | $381,000 | -3.1% | 28,316 | +1.0% | 0.01% | 0.0% |
| Q3 2015 | $393,000 | -5.1% | 28,034 | +15.0% | 0.01% | 0.0% |
| Q2 2015 | $414,000 | – | 24,380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |